🇳🇴 Bodø/Glimt og Novo Nordisk får kritikk for samarbeidsavtalen og markedsføringen
#NordicNews #Nyheter #BodøGlimt #NovoNordisk #Samarbeid #Innenriks
@nordic.skyen.live
@nordic.skyen.live🇳🇴 Bodø/Glimt og Novo Nordisk får kritikk for samarbeidsavtalen og markedsføringen
#NordicNews #Nyheter #BodøGlimt #NovoNordisk #Samarbeid #Innenriks
@nordic.skyen.live🇳🇴 Bodø/Glimt og Novo Nordisk møter kritikk for samarbeidsavtalen og markedsføringen
#NordicNews #Nyheter #BodøGlimt #NovoNordisk #Samarbeid #Innenriks
@eueconomics.bsky.social🇩🇰 Novo drops Nordisk: “Just about time”
Novo has rebranded for marketing purposes, signaling a broader strategic shift toward being more commercial and customer-focused, according to experts.
@eu-economics.wsocial.eu🇩🇰 Novo drops Nordisk: “Just about time”
Novo has rebranded for marketing purposes, signaling a broader strategic shift toward being more commercial and customer-focused, according to experts.
@businessam.bsky.socialNovo Nordisk kiest voor nieuwe naam om zichtbaarheid op de markt van medicijnen tegen obesitas te vergroten #NovoNordisk #Geneesmiddelen #Obesitas #Rebranding #Gezondheid
@businessam-fr.bsky.socialNovo Nordisk opte pour un nouveau nom afin d’accroître sa visibilité sur le marché des médicaments contre l’obésité #NovoNordisk #Obésité #Médicaments #Santé #Visibilité
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about another AstraZeneca trial failure, a Novo name change, and more news.. statnews.com/pharmalot/20... #pharma #Trump #Medicare #Medicaid #NovoNordisk #pollution #weightloss #muscle #AstraZeneca
@quartzmedia.bsky.socialNovo Nordisk drops 'Nordisk' as it scrambles to catch Eli Lilly #NovoNordisk #EliLilly
@pharmaphorum.bsky.socialEmbroiled in a fight to retain market share in weight loss and diabetes therapies, #NovoNordisk has #rebranded and launched a new #corporateculture that aims to foster "greater focus, speed, and impact."
@nordic.skyen.live🇳🇴 Bodø/Glimt samarbeider med Novo Nordisk
@jlsweekly.bsky.socialJLSW Daily Brief #092 (Sep 9): Kyowa Kirin's anti-VEGF eye drop KHK4951 misses primary endpoint in nAMD Ph2. Medipal names new CEO after 14 yrs. Novo halts 2 more heart trials.
#KyowaKirin #NovoNordisk #LifeSciencesJapan
https://jlsweekly.substack.com/p/vegfkhk4951p2novo-nordisk2
@thedailyfathom.bsky.socialBIOTECH · Novo Nordisk halts two heart trials of ziltivekimab
A data-monitoring committee found the trials unlikely to succeed, another blow to the inflammation theory of heart disease.
@newsmason.bsky.social#trends today for 'novo nordisk' 'world’s largest' & 'clarity act'
Click/Tap below:
www.newsmason.com?query=%22nov...
www.newsmason.com?query=%22wor...
www.newsmason.com?query=%22cla...
#novonordisk #world’slargest #clarityact
@pharmaphorum.bsky.social#NovoNordisk has opted to discontinue two late-stage trials of IL-6 inhibitor #ziltivekimab in #heartfailure, after an interim look at the data suggested they would be unlikely to show a positive result.
@newsuluruspace.bsky.socialProducent Ozempicu w tarapatach – tabletki mogą być rozwiązaniem
https://news.uluru.space/article/19285?utm_source=bluesky&utm_medium=social&utm_campaign=auto #NovoNordisk #Ozempic #Tabletki
@newsmonkey.bsky.socialAfslankpil Wegovy komt op de markt in Duitse apotheken #Wegovy #afslankpil #gezondheid #Duitsland #NovoNordisk